Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adventrx Pharmaceuticals, Inc.
ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
March 28th, 2008
ADVENTRX Pharmaceuticals, Inc. (AMEX:ANX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of cancer and infectious disease, reported financial results for the fourth quarter and year ended December 31, 2007. Three-Month Period Ended December 31, 2007 Operating Results ADVENTRX's net loss was $5.4 million, or $0.06 per share, for the three- month period ended December 31, 2007, compared to a net loss of $4.3 million, or $0.05 per share, for the same period in 2006. Included in the net loss for the three-month period ended December 31, 2007 were non-cash,...
Source: Health Business Week (2008-03-28)
|
